▶주메뉴 바로가기
▶본문 바로가기
South Korean biopharma firms Chong Kun Dang and Dong-A ST expect to launch their biosimilars in Japan without a headwind, despite escalating trade strife, as their drugs will be represented by Ja...
Celltrion announced July 19 that it has established the joint venture Vcell Healthcare in Shanghai with Hong Kong-based conglomerate Nan Fung Group to make a foray into China. Established in 1954, N...
HanAll Biopharma , a subsidiary of Daewoong Pharmaceutical, invested 5.6 billion won ($4.76 million) in Switzerland-based biotech startup Roivant Sciences’ subsidiary Immunovant Sciences, according ...
Korean biotech firm Bridge Biotherapeutics announced on July 18 that it has signed a contract with German-based pharmaceutical company Boehringer Ingelheim to license out its drug candidate BBT-877. ...
The prosecution has requested arrest warrants for Kim Tae-han, CEO of contract drug manufacturer Samsung BioLogics, and two other executives, surnamed Kim and Shim. The Seoul Central District Court ...
Kim Tae-han, president and CEO of contract drug manufacturer Samsung BioLogics, appeared again before prosecutors on July 5 to be questioned about whether he abetted the destruction of evidence in an...
South Korea’s drug authorities on July 3 revoked the permit for gene therapy drug Invossa for mislabeling and the false reporting of an ingredient used. The Ministry of Food and Drug Safety said ...
Thinking of undergoing vision-sharpening surgery but scared if things would go awry as you grow older? Taking cue of such concerns among people contemplating lasik surgery, genetic services provider ...
Shares of Kolon Group ’s bio affiliates plummeted after South Korea’s drug authorities canceled the license for gene therapy drug Invossa on May 28. According to the Ministry of Food and Drug Safe...
Korean new drug developer Syntekabio is preparing to go public, after receiving approval for a drug candidate from CJ Healthcare, according to industry sources on May 20. The company has picked KB S...
Prosecutors raided a task force office of Samsung Electronics on May 16 as part of an investigation into allegations that Samsung Group may have ordered accounting fraud by its biopharmaceutical unit...
More than 350 individuals who own stocks of Samsung BioLogics have filed a damage suit against the Samsung Group unit over its alleged accounting fraud, judicial officials said on May 13. In the ...
Celltrion Healthcare, an affiliate of major biopharmaceutical firm Celltrion, had the highest average salary among listed firms in South Korea in 2018, data showed on May 7. The firm, which handl...
A local private equity firm Wired Partners is considering joining the bid for acquiring Kyung Nam Pharm , a local drug maker known for its vitamin supplement Lemona, according to industry sources o...
South Korea’s Boryung Pharmaceutical announced on May 2 that it has launched its flagship hypertension drug Kanarb in the Philippines. “With our experience of Kanarb’s success in Korea, we aim to ...
Samsung to ramp up Galaxy Fold production
Woongjin defers final bid for Coway to Oct.
Sae-A to acquire fiberboard maker Tailim Packaging
Video-streaming war heats up in S. Korea
YG faces W6b tax penalty as Burning Sun scandal unfolds
Aveva to upgrade integrated industrial software in digital push
Ghost Kitchen secures additional W9.2b
Medytox invests in US startup LifeSprout
September 18, 2019
